A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
Clinical trial NCT07361003 · RECRUITING
Trial details
- NCT number
- NCT07361003
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-12
- Primary completion
- 2028-01-01
- Enrollment
- 464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.